NT$
169.50
Sep 13
Business Description
ICARES Medicus Inc
ISIN : TW0006612005
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.92 | |||||
Equity-to-Asset | 0.59 | |||||
Debt-to-Equity | 0.49 | |||||
Debt-to-EBITDA | 4.79 | |||||
Interest Coverage | 8.72 | |||||
Piotroski F-Score | 1/9 | |||||
Altman Z-Score | 4.68 | |||||
Beneish M-Score | -2.29 | |||||
WACC vs ROIC |
Growth Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 17.6 | |||||
3-Year EBITDA Growth Rate | 15.1 | |||||
3-Year EPS without NRI Growth Rate | 26.5 | |||||
3-Year Book Growth Rate | 27.4 |
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 89.93 | |||||
9-Day RSI | 80.06 | |||||
14-Day RSI | 71.23 | |||||
6-1 Month Momentum % | 36.52 | |||||
12-1 Month Momentum % | 19.58 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.56 | |||||
Quick Ratio | 2.32 | |||||
Cash Ratio | 1.94 | |||||
Days Inventory | 353.79 | |||||
Days Sales Outstanding | 93.35 | |||||
Days Payable | 36.93 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.13 | |||||
3-Year Dividend Growth Rate | 26 | |||||
Forward Dividend Yield % | 0.13 | |||||
5-Year Yield-on-Cost % | 0.17 | |||||
3-Year Average Share Buyback Ratio | -4.7 | |||||
Shareholder Yield % | -4.12 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 77.73 | |||||
Operating Margin % | 15.81 | |||||
Net Margin % | 10.91 | |||||
FCF Margin % | -25.6 | |||||
ROE % | 5.18 | |||||
ROA % | 3.73 | |||||
ROIC % | 2.44 | |||||
3-Year ROIIC % | 8.71 | |||||
ROC (Joel Greenblatt) % | 24.99 | |||||
ROCE % | 7.32 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 102.23 | |||||
PE Ratio without NRI | 92.33 | |||||
Shiller PE Ratio | 85.49 | |||||
PEG Ratio | 15.39 | |||||
PS Ratio | 11.07 | |||||
PB Ratio | 4.39 | |||||
Price-to-Tangible-Book | 4.77 | |||||
EV-to-EBIT | 56.42 | |||||
EV-to-EBITDA | 38.53 | |||||
EV-to-Revenue | 10.15 | |||||
EV-to-FCF | -32.14 | |||||
Price-to-Projected-FCF | 5.78 | |||||
Price-to-Peter-Lynch-Fair-Value | 10.34 | |||||
Price-to-Graham-Number | 4.43 | |||||
Price-to-Net-Current-Asset-Value | 7.91 | |||||
Price-to-Net-Cash | 17.28 | |||||
Earnings Yield (Greenblatt) % | 1.77 | |||||
FCF Yield % | -2.28 | |||||
Forward Rate of Return (Yacktman) % | 9.03 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
ICARES Medicus Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil NT$) | 644.998 | ||
EPS (TTM) (NT$) | 1.658 | ||
Beta | 0.85 | ||
Volatility % | 46.13 | ||
14-Day RSI | 71.23 | ||
14-Day ATR (NT$) | 7.407541 | ||
20-Day SMA (NT$) | 143.7 | ||
12-1 Month Momentum % | 19.58 | ||
52-Week Range (NT$) | 96.363636 - 174.5 | ||
Shares Outstanding (Mil) | 43.08 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 1 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
ICARES Medicus Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
ICARES Medicus Inc Stock Events
Event | Date | Price(NT$) | ||
---|---|---|---|---|
No Event Data |
ICARES Medicus Inc Frequently Asked Questions
What is ICARES Medicus Inc(ROCO:6612)'s stock price today?
When is next earnings date of ICARES Medicus Inc(ROCO:6612)?
Does ICARES Medicus Inc(ROCO:6612) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |